Recurrence Prevention

Targeting Dormant Tumor Cells: A Promising Strategy to Prevent Breast Cancer Recurrence

A phase 2 randomized trial demonstrates that targeting dormant disseminated tumor cells with hydroxychloroquine and everolimus is safe, feasible, and reduces minimal residual disease, potentially improving recurrence-free survival in breast